Evolution of the Average Target: DR Horton

Data source: DR Horton(DHI)
Evolution of the Average Target - DR Horton

Evolution of the Target Price: DR Horton

Data source: DR Horton(DHI)
Evolution of the Target Price - DR Horton

Changes in Analyst Recommendations: DR Horton

Data source: DR Horton(DHI)
7fbfd8e372209.DGHX1Qz-RfIpHTUAu2-ybWib_KYM4TA_VlwNxBae_C8.dAKfikORfJ5bS14w7SblPxirr8MhmFZ7DytPsnL5j25cFablbZ0MwBx2Rg~dace524426086b71256626778111a939
06/10 Barclays Adjusts D.R. Horton Price Target to $130 From $141, Maintains Equal Weight Rating MT
01/10 Morgan Stanley Initiates D.R. Horton at Equalweight With $151 Price Target MT
25/09 Evercore ISI Adjusts Price Target on D.R. Horton to $166 From $177, Maintains In Line Rating MT
22/09 Keefe Bruyette & Woods Adjusts PT on D.R. Horton to $160 From $167, Keeps Market Perform Rating MT
22/09 BTIG Adjusts Price Target on D.R. Horton to $174 From $184, Keeps Buy Rating MT
21/09 Keefe, Bruyette & Woods Adjusts Price Target on D.R. Horton to $160 From $167 MT
18/09 Wall Street's Relief Has Limits Zonebourse
16/09 Meritage Homes Likely to Increase Homebuyer Incentives Amid High Mortgage Rates, Truist Says MT
16/09 Truist Cuts Price Target on D.R. Horton to $140 From $150, Keeps Hold Rating MT
11/09 Wells Fargo Adjusts Price Target on D.R. Horton to $145 From $155, Maintains Equalweight Rating MT
04/08 Wells Fargo Adjusts Price Target on D.R. Horton to $155 From $170, Maintains Equalweight Rating MT
22/07 Citigroup Adjusts Price Target on D.R. Horton to $160 From $173, Maintains Neutral Rating MT
22/07 BTIG Adjusts Price Target on D.R. Horton to $184 From $188, Maintains Buy Rating MT
22/07 RBC Lifts Price Target on D.R. Horton to $125 From $123, Keeps Underperform Rating MT
22/07 Keefe Bruyette & Woods Adjusts PT on D.R. Horton to $167 From $175, Maintains Market Perform Rating MT
22/07 Goldman Sachs Adjusts Price Target on D.R. Horton to $190 From $186, Maintains Buy Rating MT
22/07 Evercore ISI Adjusts Price Target on D.R. Horton to $177 From $171, Maintains In Line Rating MT
14/07 Barclays Adjusts Price Target on D.R. Horton to $141 From $140, Maintains Equalweight Rating MT
10/07 Goldman Sachs Adjusts Price Target on D.R. Horton to $186 From $190 MT
09/07 D.R. Horton Quarterly Earnings Poised for Beat Amid Multiple Tailwinds, Oppenheimer Says MT
22/04 UBS Adjusts D.R. Horton Price Target to $206 From $193, Maintains Buy Rating MT
22/04 Truist Raises Price Target on D.R. Horton to $150 From $140, Keeps Hold Rating MT
22/04 Citigroup Adjusts Price Target on D.R. Horton to $173 From $162, Maintains Neutral Rating MT
22/04 Keefe, Bruyette & Woods Adjusts Price Target on D.R. Horton to $175 From $163, Maintains Market Perform Rating MT
22/04 Evercore ISI Adjusts Price Target on D.R. Horton to $171 From $153, Maintains In Line Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+18.82%
+22.83%
+6.13%
+17.92%
+7.89%
+16.54%
+26.03%
+5.34%
Average +15.19%
Weighted average by Cap. +16.31%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
136.75USD
Average target price
157.46USD
Spread / Average Target
+15.15%
High Price Target
206.00USD
Spread / Highest target
+50.64%
Low Price Target
125.00USD
Spread / Lowest Target
-8.59%

Analyst Consensus Detail

Analyst consensus - DR Horton

Consensus revision (last 18 months)

Consensus revision (last 18 months) - DR Horton
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - DR Horton